UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force

European journal of neurology, 2006-09, Vol.13 (9), p.913-922

2006

Volltextzugriff (PDF)

EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104

British journal of cancer, 2013-02, Vol.108 (2), p.469-476

2013

Volltextzugriff (PDF)

EFNS guidelines on disease-specific CSF investigations

European journal of neurology, 2009-06, Vol.16 (6), p.760-e163

2009

Volltextzugriff (PDF)

Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis

Multiple sclerosis, 2001-10, Vol.7 (5), p.285-289

2001

Volltextzugriff (PDF)

Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis

Multiple sclerosis, 2001-10, Vol.7 (5), p.285-289

2001

Volltextzugriff (PDF)

Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativity

Multiple sclerosis, 2004-10, Vol.10 (5), p.507-510

2004

Volltextzugriff (PDF)

Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patients

Multiple sclerosis, 2006-12, Vol.12 (6), p.731-737

2006

Volltextzugriff (PDF)

Autonomic instability, as measured by pupillary unrest, is not associated with multiple sclerosis fatigue severity

Multiple sclerosis, 2002-05, Vol.8 (3), p.256-260

2002

Volltextzugriff (PDF)

Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event

The New England journal of medicine, 2003-07, Vol.349 (2), p.139-145

2003

Volltextzugriff (PDF)

Interferon-β antibodies have a higher affinity in patients with neutralizing antibodies compared to patients with non-neutralizing antibodies

Journal of neuroimmunology, 2006-05, Vol.174 (1), p.174-179

2006

Volltextzugriff (PDF)

The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL

Neurology, 2007-10, Vol.69 (14), p.1391-1403

2007

Volltextzugriff (PDF)

Biomass losses during harvest and storage of switchgrass

Biomass & bioenergy, 1997, Vol.12 (2), p.107-114

1997

Volltextzugriff (PDF)

A novel and rapid assay for the detection of neutralizing antibodies against interferon-beta

Multiple sclerosis, 2003-02, Vol.9 (1), p.32-35

2003

Volltextzugriff (PDF)

Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study

Brain (London, England : 1878), 1999-11, Vol.122 (11), p.2047-2056

1999

Volltextzugriff (PDF)

Chemotherapy-induced immunological breast cancer dormancy: a new function for old drugs?

Journal of cancer metastasis and treatment, 2019-05, Vol.2019

2019

Volltextzugriff (PDF)

Improving the culture of interdisciplinary collaboration in ecology by expanding measures of success

Frontiers in ecology and the environment, 2014-02, Vol.12 (1), p.39-47

2014

Volltextzugriff (PDF)

FK506-binding Proteins 51 and 52 Differentially Regulate Dynein Interaction and Nuclear Translocation of the Glucocorticoid Receptor in Mammalian Cells

The Journal of biological chemistry, 2005-02, Vol.280 (6), p.4609-4616

2005

Volltextzugriff (PDF)

Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis

Journal of the neurological sciences, 2010-05, Vol.292 (1), p.28-35

2010

Volltextzugriff (PDF)

Evaluations of Correctional Treatment Programs in Germany: A Review and Meta-Analysis

Substance use & misuse, 2000-01, Vol.35 (12-14), p.1967-2009

2000

Volltextzugriff (PDF)

Completing the data life cycle: using information management in macrosystems ecology research

Frontiers in ecology and the environment, 2014-02, Vol.12 (1), p.24-30

2014

Volltextzugriff (PDF)

Degradable Mg scaffolds produced by selective laser melting

Frontiers in bioengineering and biotechnology, 2016, Vol.4

2016

Volltextzugriff (PDF)

Theatre Cultures within Globalising Empires: Looking at Early Modern England and Spain

1st edition., 2018

Volltextzugriff (PDF)

The Patient Griselda Myth: Looking at Late Medieval and Early Modern European Literature

Rüegg, Madeline

1, 2019

Volltextzugriff (PDF)

Increased serum levels of soluble CD14 indicate stable multiple sclerosis

Journal of neuroimmunology, 2006-12, Vol.181 (1), p.145-149

2006

Volltextzugriff (PDF)

Molecular markers of the EGFR pathway in erlotinib-treated patients with advanced pancreatic cancer (APC): Translational analyses of a randomized, cross-over AIO phase III trial

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4047-4047

2011

Volltextzugriff (PDF)

1 – 25 von 270

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(197)
Mit Volltextzugriff
(233)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(135)
Life Sciences & Biomedicine
(119)
Humans
(70)
Animals
(49)
Male
(45)
Female
(44)
Biological And Medical Sciences
(43)
Adult
(32)
Physiology
(30)
Neurosciences & Neurology
(25)
Fundamental And Applied Biological Sciences. Psychology
(24)
Neurosciences
(23)
Middle Aged
(22)
Medical Sciences
(21)
Judaism
(18)
Ancient Religions & Mythologies
(17)
History Of Religion
(17)
Muscle Contraction
(16)
Agriculture
(14)
Calcium - Pharmacology
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force

EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104

EFNS guidelines on disease-specific CSF investigations

Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis

Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis

Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativity

Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patients

Autonomic instability, as measured by pupillary unrest, is not associated with multiple sclerosis fatigue severity

Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event

Interferon-β antibodies have a higher affinity in patients with neutralizing antibodies compared to patients with non-neutralizing antibodies

The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL

Biomass losses during harvest and storage of switchgrass

A novel and rapid assay for the detection of neutralizing antibodies against interferon-beta

Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study

Chemotherapy-induced immunological breast cancer dormancy: a new function for old drugs?

Improving the culture of interdisciplinary collaboration in ecology by expanding measures of success

FK506-binding Proteins 51 and 52 Differentially Regulate Dynein Interaction and Nuclear Translocation of the Glucocorticoid Receptor in Mammalian Cells

Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis

Evaluations of Correctional Treatment Programs in Germany: A Review and Meta-Analysis

Completing the data life cycle: using information management in macrosystems ecology research

Degradable Mg scaffolds produced by selective laser melting

Theatre Cultures within Globalising Empires: Looking at Early Modern England and Spain

The Patient Griselda Myth: Looking at Late Medieval and Early Modern European Literature

Increased serum levels of soluble CD14 indicate stable multiple sclerosis

Molecular markers of the EGFR pathway in erlotinib-treated patients with advanced pancreatic cancer (APC): Translational analyses of a randomized, cross-over AIO phase III trial

Suchergebnisse filtern